Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Derivatives of ergostatrien-3-β-ol from antrodia camphorata and antiglycemic, antihyperlipidemic and decreasing hepatic fat use thereof

Derivatives of ergostatrien-3-β-ol from antrodia camphorata and antiglycemic, antihyperlipidemic and decreasing hepatic fat use thereof

US Patent 9757393 · Granted Sep 12, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of benzofuran lignans to induce IL-25 expression and suppress mammary tumor 2021
Caffeic acid derivatives for anti-angiogenesis2021
Use of dehydroeburicoic acid from Antrodia camphorata in the treatment or preven2019
Use of dehydroeburicoic acid from Antrodia camphorata in the treatment or preven2019
Use of dehydroeburicoic acid from Antrodia camphorata in the treatment or preven2019
Method for treatment of hyperglycemia and hyperlipidemia2018
Method for treatment of hyperglycemia and hyperlipidemia2018
Method for treatment of hyperglycemia and hyperlipidemia2018
Method and composition for treatment or prevention of type 2 diabetes and hyperl2018
Method and composition for treatment or prevention of type 2 diabetes and hyperl2018
Method of treating or preventing hyperlipidemia with caffeamide derivatives2017
Method of treating or preventing hyperlipidemia with caffeamide derivatives2017